ProQR Therapeutics

$4.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.36 (-7.44%) Today

$0.00 (0.00%) As of 9:46 PM UTC after-hours

Why Robinhood?

You can buy or sell PRQR and other stocks, options, and ETFs commission-free!

About PRQR

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands. The listed name for PRQR is ProQR Therapeutics N.V. Ordinary Shares.

CEO

Daniel Anton de Boer

Employees

154

Headquarters

Leiden, Zuid-Holland

Founded

2012

Market Cap

210.37M

Price-Earnings Ratio

—

Dividend Yield

0.00

Average Volume

566.34K

High Today

$4.85

Low Today

$4.30

Open Price

$4.80

Volume

455.72K

52 Week High

$8.69

52 Week Low

$3.40

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

PRQR Earnings

-$0.43

-$0.29

-$0.14

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Feb 25, Pre-Market